To get a sense of who is truly in control of Biome Australia Limited (ASX:BIO), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the ...

Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has announced that it expects to surpass its upgraded FY24 revenue forecast of $12.5 million, marking a second consecutive ...

Biome Australia Ltd (ASX:BME) reported its Q1 FY26 earnings, revealing a strong financial performance that drove a 10.64% increase in its stock price during pre-market trading. The company’s revenue ...

Overview: Biome Australia Limited develops, commercializes, and markets various live biotherapeutics and complementary medicines in Australia and internationally, with a market cap of A$150.10 million ...

Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has successfully identified and validated its new probiotic strain, Lactobacillus plantarum BMB18, marking a significant ...

Biome Australia Limited (ASX:BIO) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 23% resulting in a AU$18m addition to the company’s market ...

Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has released a company presentation outlining its current strategy and investment opportunities, highlighting the company’s ...

Biome Australia Ltd (AU:BIO) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly ...

Biome Australia develops, commercialises and markets evidence-based live biotherapeutics and complementary medicines with clinically proven health benefits. It aims to prevent disease, improve health ...